Morning Overview on MSN
1 gene explains how inflammation can push kidneys toward failure
Inflammation has long been a warning sign in kidney clinics, a red flag that often appears years before a patient tips into ...
The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
The Brighterside of News on MSN
Single gene reveals why inflammation triggers kidney failure
Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...
Medeor Therapeutics’ kidney transplant cell therapy, which combines a living donor’s cells with the recipient's, allowed more than half of study participants in a phase 3 pivotal trial to stay off ...
aProximate TM is an advanced in vitro model of kidney proximal tubule cells (PTCs) that closely mimics physiological conditions. Derived from fresh human kidney tissue, aProximate TM PTCs are cultured ...
High blood pressure could do more damage than you think.A research team from the Medical University of Vienna has discovered ...
Researches made major strides toward the creation of artificial kidney tissue by demonstrating an undiscovered mechanism behind kidney development and a novel technique for culturing kidney cells, ...
Acute kidney injury (AKI) often occurs as a result of ischemia, which is a condition in which blood flow to part of the body is restricted, depriving tissues of oxygen and nutrients. This damage is ...
News-Medical.Net on MSN
Trial evaluates a traditional Chinese herbal formula for diabetic kidney disease with macroalbuminuria
Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...
Symptoms of stage 3 RCC vary; some patients experience blood in the urine, flank pain, fatigue, weight loss, or a palpable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results